The effects of intradermal and topical mitomycin C on wound healing

Otolaryngology - Head and Neck Surgery

Volumn 135, Issue 1, 2006, Pages 56-60

  Porter, Glen T ^a   Gadre, Swarupa A ^b   Calhoun, Karen H ^c  

^a Nellis Air Force Base   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c UNIVERSITY OF MISSOURI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EOSIN; HEMATOXYLIN; MITOMYCIN C; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; HISTOLOGY; IMMUNOHISTOCHEMISTRY; NONHUMAN; PROSPECTIVE STUDY; RAT; SKIN NECROSIS; TISSUE INTERACTION; TREATMENT OUTCOME; WOUND; WOUND HEALING;

ANIMALS; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; FIBROBLASTS; FOLLOW-UP STUDIES; IMMUNOHISTOCHEMISTRY; INJECTIONS, INTRADERMAL; INJECTIONS, INTRALESIONAL; MALE; MITOMYCIN; NUCLEIC ACID SYNTHESIS INHIBITORS; RATS; RATS, SPRAGUE-DAWLEY; SKIN; TREATMENT OUTCOME; WOUND HEALING;

EID: 33745400572     PISSN: 01945998     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.otohns.2006.02.024     Document Type: Article

References (15)

1. Prasad M., Ward R., April M., et al. Topical mitomycin as an adjunct to choanal atresia repair. Arch Otolaryngol Head Neck Surg 128 4 (2002) 398-400 (Grade C).
2. Rombaux P., de Toeuf C., Hamoir M., et al. Transnasal repair of unilateral choanal atresia. Rhinology 41 1 (2003) 31-36 (Grade B).
3. Jassir D., Buchman C., Gomez-Marin O., et al. Safety and efficacy of topical mitomycin C in myringotomy patency. Otolaryngol Head Neck Surg 124 4 (2001) 368-373 (Grade A).
4. Kim J, Stewart C. Applications for mitomycin C for H-N keloids. Presented at the Annual Meeting of the American Academy of Otolaryngology-Head and Neck Surgery Foundation; September, 2004; New York, New York.
5. Simman R., Alani H., Williams F., et al. Effect of mitomycin C on keloid fibroblasts. an in vitro study. Ann Plast Surg 50 1 (2003) 71-76 (Grade A).
6. Ingrams D., Volk M., Biesman B., et al. Sinus surgery. does mitomycin C reduce stenosis?. Laryngoscope 108 6 (1998) 883-886 (Grade A).
7. Spector J., Werkhaven J., Spector N., et al. Preservation of function and histologic appearance in the injured glottis with topical mitomycin C. Laryngoscope 109 7, part 1 (1999) 1125-1129 (Grade A).
8. Gray S., Tritle N., Li W., et al. The effect of mitomycin on extracellular matrix proteins in a rat wound model. Laryngoscope 113 2 (2003) 237-242 (Grade A).
9. Ihnat M., Nervi A., Anthony S., et al. Effects of mitomycin C and carboplatin pretreatment on multidrug resistance-associated P-glycoprotein expression and on subsequent suppression of tumor growth by doxorubicin and paclitaxel in human metastatic breast cancer xenografted nude mice. Oncol Res 11 7 (1999) 303-310 (Grade A).
10. Niessen F., Spauwen P., Schalkwijk J., et al. On the nature of hypertrophic scars and keloids. a review. Plast Reconstr Surg 104 (1999) 1435 (Grade A).
11. Wang R., Ghahary A., Shen Q., et al. Hypertrophic scar tissues and fibroblasts produce more transforming growth-factor beta 1 mRNA and protein than normal skin and cells. Wound Repair Regen 8 2 (2000) 128 (Grade A).
12. Lee T., Chin G., Kim W., et al. Expression of transforming growth factor-beta1, 2, and 3 proteins in keloids. Ann Plast Surg 43 (1999) 179-184 (Grade A).
13. Polo M., Smith P., Kim Y., et al. Effect of TGF-beta 2 on proliferative scar fibroblast cell kinetics. Ann Plast Surg 43 2 (1999) 185-190 (Grade A).
14. Ehrlich H., Keefer K., Maish G., et al. Vandate ingestion increases the gain in wound breaking strength and leads to better organized collagen fibers in rats during healing. Plast Reconstr Surg 107 2 (2001) 471-477 (Grade A).
15. Mosby's Drug Consult. St Louis: Mosby-Year Book, Inc; 2002.